Form 4: Tyra Biosciences Insider Buys Shares
Insider Transaction (Form 4)
Ra Capital Management, L.P. and 4 others reported changes in beneficial ownership of Tyra Biosciences, Inc. common stock on September 15, 2026.
Summary
- Open-market purchase: acquired 9,078,529 Pre-Funded Warrants (Right to Buy) at $22.03 ($199,990,915) on September 15, 2026; holds 11,616,986 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $199,990,915, committing personal capital to the stock.
Insider Transactions
Ra Capital Management, L.P. — Director, 10% owner
RA Capital Healthcare Fund LP — Director, 10% owner
RA Capital Nexus Fund, L.P. — Director
Peter Kolchinsky — Director, 10% owner
Rajeev M. Shah — Director, 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Open-market purchase | Pre-Funded Warrants (Right to Buy) | 9,078,529 | $22 | $200.0M | 11,616,986 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Open-market purchase (9,078,529 shares) |
Keywords
insider transaction, Form 4, TYRA, Tyra Biosciences, Inc., bullish, Ra Capital Management, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Peter Kolchinsky, Rajeev M. Shah
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.